» Articles » PMID: 18573327

Tyrosinase Inhibition by Extracts and Constituents of Sideroxylon Inerme L. Stem Bark, Used in South Africa for Skin Lightening

Overview
Date 2008 Jun 25
PMID 18573327
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the stem bark of Sideroxylon inerme L. and its compounds for tyrosinase-inhibition activity and to evaluate the mechanism involved of the most potent compounds in tyrosinase inhibition.

Materials And Methods: Three different extracts (acetone, methanol and dichloromethane) of Sideroxylon inerme L. were evaluated for their inhibitory effect in vitro on the monophenolase and diphenolase activated forms of tyrosinase, using a colorimetric procedure. This test was used for bioactivity-guided isolation of two active compounds using column chromatography and TLC. Active extracts were also investigated for their inhibitory effect on melanogenesis in cultured B16 melanoma cells. Antioxidant activities of the methanolic extract of Sideroxylon inerme and purified compounds were investigated using the 1,2-diphenyl-2-picrylhydrazyl (DPPH) antioxidant assay. The inhibition of tyrosinase activity relative to the inhibition of its activity at the transcriptional level was also studied by determination of the degree of expression of mRNAs for this gene by using extract of Sideroxylon inerme-treated cells (B16F10) and semi-quantitative RT-PCR.

Results: Methanolic and acetonic extracts of the stem bark of Sideroxylon inerme showed significant inhibition of monophenolase activity (IC50 values of 63 microg/ml and 82 microg/ml, respectively). The methanolic extract also exhibited 37% reduction of melanin content at 6.2 microg/ml in melanocytes without being significantly toxic to the cells. Examination for inhibition of monophenoloxidase in situ on TLC, followed by column chromatographic purification of the stem bark extract of Sideroxylon inerme, resulted in the isolation of two active compounds, epigallocatechin gallate and procyanidin B1, with IC50 values against monophenolase of 30 microg/ml and > 200 microg/ml, respectively. Epigallocatechin gallate exhibited a greater anti-tyrosinase activity than arbutin. Sideroxylon inerme bark extracts, epigallocatechin gallate and procyanidin B1 exhibited antioxidant DPPH radical scavenging activities with EC50 values of 1.54 microg/ml, 1.33 microg/ml and 1.68 microg/ml, respectively and were not particularly cytotoxic. During mechanism studies it was evident that at the transcription level, Sideroxylon inerme (25 microg/ml) was acting as a potent tyrosinase inhibitor compared to controls (untreated cells and kojic acid).

Conclusion: The bark extract of Sideroxylon inerme and the two isolated compounds warrant further investigation in clinical studies to be considered as skin-depigmenting agents.

Citing Articles

Marine cosmetics and the blue bioeconomy: From sourcing to success stories.

Rotter A, Varamogianni-Mamatsi D, Zvonar Pobirk A, Matjaz M, Cueto M, Diaz-Marrero A iScience. 2024; 27(12):111339.

PMID: 39650733 PMC: 11625311. DOI: 10.1016/j.isci.2024.111339.


Insights on Essential Oil as Potential Anti-Proliferative, Anti-Tyrosinase, and Antioxidant Candidate.

Mansour R, Wasli H, Bourgou S, Khamessi S, Ksouri R, Megdiche-Ksouri W Molecules. 2023; 28(22).

PMID: 38005268 PMC: 10673065. DOI: 10.3390/molecules28227547.


Synthesis, In Silico Studies, and Antioxidant and Tyrosinase Inhibitory Potential of 2-(Substituted Phenyl) Thiazolidine-4-Carboxamide Derivatives.

Zargaham M, Ahmed M, Akhtar N, Ashraf Z, Abdel-Maksoud M, Aufy M Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375782 PMC: 10303221. DOI: 10.3390/ph16060835.


Solvent-Free Microwave Extraction of Essential Oils from (Lour.) Pers. at Different Harvesting Times and Their Skin-Whitening Cosmetic Potential.

Qiu Y, Wang Y, Li Y Antioxidants (Basel). 2022; 11(12).

PMID: 36552598 PMC: 9774158. DOI: 10.3390/antiox11122389.


Nomilin from Yuzu Seed Has In Vitro Antioxidant Activity and Downregulates Melanogenesis in B16F10 Melanoma Cells through the PKA/CREB Signaling Pathway.

Choi M, Yang S, Kim N, Shin H Antioxidants (Basel). 2022; 11(9).

PMID: 36139710 PMC: 9495840. DOI: 10.3390/antiox11091636.